Timber Creek Capital Management LLC Abb Vie Inc. Transaction History

Timber Creek Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$138.31 - $165.87 $4,149 - $4,976	-30 Closed	0 $0
Q2 2022 Jul 13, 2022	SELL	$137.62 - $174.96 $4,128 - $5,248	-30 Reduced 50.0%	30 $4,000
Q3 2021 Oct 08, 2021	SELL	$106.4 - $120.78 $11,704 - $13,285	-110 Reduced 64.71%	60 $6,000
Q2 2021 Jul 29, 2021	SELL	$105.21 - $117.21 $6,312 - $7,032	-60 Reduced 26.09%	170 $19,000
Q1 2021 Apr 19, 2021	SELL	$102.3 - $112.62 $6,138 - $6,757	-60 Reduced 20.69%	230 $24,000
Q2 2020 Jul 31, 2020	SELL	$73.37 - $98.18 $7,337 - $9,818	-100 Reduced 25.64%	290 $28,000
Q1 2020 Apr 17, 2020	SELL	$64.5 - $97.79 $6,450 - $9,779	-100 Reduced 20.41%	390 $29,000
Q4 2018 Jan 30, 2019	BUY	$77.85 - $96.01 $8,563 - $10,561	110 Added 28.95%	490 $45,000
Q1 2018 Apr 30, 2018	SELL	$92.01 - $123.21 $1,840 - $2,464	-20 Reduced 5.0%	380 $35,000
Q2 2017 Aug 11, 2017	BUY	N/A	400	400 $26,000

3,696

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $345B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Timber Creek Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Timber Creek Capital Management LLC with notifications on news.